An assessment of the composite TE biomarkers Cu/Se ratio and CP/SELENOP ratio, respectively, yielded two novel sensitive and promising diagnostic parameters of SSc and SSc-related PAH, that may enable an early and reliable identification of disease activity and PAH risk. This evidence concerns the gene CP and pulmonary arterial hypertension.